Intellectual Property India Publishes Patent Application for 'Imidazopyridine Compounds, Preparation Thereof And Therapeutic Uses Thereof' Filed by Sanofi

MUMBAI, India, May 30 -- Intellectual Property India has published a patent application (202517013971 A) filed by Sanofi, Paris, on Feb. 18, for 'imidazopyridine compounds, preparation thereof and therapeutic uses thereof.'

Inventor(s) include Begis, Guillaume; Bernardelli, Patrick; Devillers, Ingrid; Marcireau, Christophe; Slowinski, Franck; Zhang, Jidong; Auger, Florian Alain; Duteil, Virginie Rosine; Arranz Plaza, Maria Esther; and Certal, Victor.

The application for the patent was published on May 30, under issue no. 22/2025.

According to the abstract released by the Intellectual Property India: "Compound are provided which can inhibit ERK5. Also provided are pharmaceutical compositions and medical uses of the same, including the use in treating or preventing conditions such as cancers."

The patent application was internationally filed on July 19, 2023, under International application No.PCT/EP2023/070084.

Disclaimer: Curated by HT Syndication.